{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:08:54Z","timestamp":1761808134667,"version":"3.40.3"},"publisher-location":"Dordrecht","reference-count":25,"publisher":"Springer Netherlands","isbn-type":[{"type":"print","value":"9789402410778"},{"type":"electronic","value":"9789402410792"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-94-024-1079-2_56","type":"book-chapter","created":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T04:54:12Z","timestamp":1503896052000},"page":"717-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Taurine on iNOS-Mediated DNA Damage in Drug-Induced Renal Injury"],"prefix":"10.1007","author":[{"given":"Toshihiro","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tsunekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takenori","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"56_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1476-5829.2007.00142.x","volume":"6","author":"K Barabas","year":"2008","unstructured":"Barabas K, Milner R, Lurie D, Adin C (2008) Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol 6:1\u201318","journal-title":"Vet Comp Oncol"},{"key":"56_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.etp.2008.09.003","volume":"61","author":"YI Chirino","year":"2009","unstructured":"Chirino YI, Pedraza-Chaverri J (2009) Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 61:223\u2013242","journal-title":"Exp Toxicol Pathol"},{"key":"56_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u2013378","journal-title":"Eur J Pharmacol"},{"key":"56_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.tox.2013.05.015","volume":"310","author":"R Domitrovic","year":"2013","unstructured":"Domitrovic R, Cvijanovic O, Pugel EP, Zagorac GB, Mahmutefendic H, Skoda M (2013) Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney. Toxicology 310:115\u2013123","journal-title":"Toxicology"},{"key":"56_CR5","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","volume":"86","author":"NA dos Santos","year":"2012","unstructured":"dos Santos NA, Carvalho Rodrigues MA, Martins NM, dos Santos AC (2012) Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update. Arch Toxicol 86:1233\u20131250","journal-title":"Arch Toxicol"},{"key":"56_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-1-4615-3436-5_38","volume":"315","author":"RE Gordon","year":"1992","unstructured":"Gordon RE, Heller RF (1992) Taurine protection of lungs in hamster models of oxidant injury: a morphologic time study of paraquat and bleomycin treatment. Adv Exp Med Biol 315:319\u2013328","journal-title":"Adv Exp Med Biol"},{"key":"56_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s007260070002","volume":"19","author":"X Han","year":"2000","unstructured":"Han X, Budreau AM, Chesney RW (2000) The taurine transporter gene and its role in renal development. Amino Acids 19:499\u2013507","journal-title":"Amino Acids"},{"key":"56_CR8","first-page":"47","volume":"1","author":"MH Hanigan","year":"2003","unstructured":"Hanigan MH, Devarajan P (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 1:47\u201361","journal-title":"Cancer Ther"},{"key":"56_CR9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1152\/physrev.1968.48.2.424","volume":"48","author":"JG Jacobsen","year":"1968","unstructured":"Jacobsen JG, Smith LH (1968) Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48:424\u2013511","journal-title":"Physiol Rev"},{"key":"56_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/978-3-319-15126-7_62","volume":"803","author":"T Kato","year":"2015","unstructured":"Kato T, Okita S, Wang S, Tsunekawa M, Ma N (2015) The effects of taurine administration against inflammation in heavily exercised skeletal muscle of rats. Adv Exp Med Biol 803:773\u2013784","journal-title":"Adv Exp Med Biol"},{"key":"56_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573\u2013584","journal-title":"Nat Rev Cancer"},{"key":"56_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","volume":"24","author":"PE Kintzel","year":"2001","unstructured":"Kintzel PE (2001) Anticancer drug-induced kidney disorders. Drug Saf 24:19\u201338","journal-title":"Drug Saf"},{"key":"56_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/PL00006741","volume":"45","author":"R Kroning","year":"2000","unstructured":"Kroning R, Lichtenstein AK, Nagami GT (2000) Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines. Cancer Chemother Pharmacol 45:43\u201349","journal-title":"Cancer Chemother Pharmacol"},{"key":"56_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/42.5.7908911","volume":"42","author":"N Ma","year":"1994","unstructured":"Ma N, Aoki E, Semba R (1994) An immunohistochemical study of aspartate, glutamate, and taurine in rat kidney. J Histochem Cytochem 42:621\u2013626","journal-title":"J Histochem Cytochem"},{"key":"56_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","volume":"8","author":"SR McWhinney","year":"2009","unstructured":"McWhinney SR, Goldberg RM, McLeod HL (2009) Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther 8:10\u201316","journal-title":"Mol Cancer Ther"},{"key":"56_CR16","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1046\/j.1523-1755.2002.00317.x","volume":"61","author":"MS Mozaffari","year":"2002","unstructured":"Mozaffari MS, Schaffer SW (2002) Chronic taurine treatment ameliorates reduction in saline-induced diuresis and natriuresis. Kidney Int 61:1750\u20131759","journal-title":"Kidney Int"},{"key":"56_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0895-7061(03)00915-4","volume":"16","author":"MS Mozaffari","year":"2003","unstructured":"Mozaffari MS, Miyata N, Schaffer SW (2003) Effects of taurine and enalapril on kidney function of the hypertensive glucose-intolerant rat. Am J Hypertens 16:673\u2013680","journal-title":"Am J Hypertens"},{"key":"56_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","volume":"73","author":"N Pabla","year":"2008","unstructured":"Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994\u20131007","journal-title":"Kidney Int"},{"key":"56_CR19","first-page":"371","volume":"179","author":"H Pasantes-Morales","year":"1985","unstructured":"Pasantes-Morales H, Cruz C (1985) Taurine: a physiological stabilizer of photoreceptor membranes. Prog Clin Biol Res 179:371\u2013381","journal-title":"Prog Clin Biol Res"},{"key":"56_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.semnephrol.2010.09.005","volume":"30","author":"MA Perazella","year":"2010","unstructured":"Perazella MA, Moeckel GW (2010) Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention\/therapy. Semin Nephrol 30:570\u2013581","journal-title":"Semin Nephrol"},{"key":"56_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0272-6386(86)80112-3","volume":"8","author":"F Ries","year":"1986","unstructured":"Ries F, Klastersky J (1986) Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 8:368\u2013379","journal-title":"Am J Kidney Dis"},{"key":"56_CR22","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/MOO.0b013e3282eee452","volume":"15","author":"LP Rybak","year":"2007","unstructured":"Rybak LP (2007) Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr Opin Otolaryngol Head Neck Surg 15:364\u2013369","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"56_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00210-001-0524-8","volume":"365","author":"S Sato","year":"2002","unstructured":"Sato S, Yamate J, Saito T, Hosokawa T, Saito S, Kurasaki M (2002) Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin. Naunyn Schmiedeberg\u2019s Arch Pharmacol 365:277\u2013283","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"56_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-4614-6130-2_20","volume":"775","author":"H Sugiura","year":"2013","unstructured":"Sugiura H, Okita S, Kato T, Naka T, Kawanishi S, Ohnishi S, Oshida Y, Ma N (2013) Protection by taurine against INOS-dependent DNA damage in heavily exercised skeletal muscle by inhibition of the NF-kappaB signaling pathway. Adv Exp Med Biol 775:237\u2013246","journal-title":"Adv Exp Med Biol"},{"key":"56_CR25","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/0024-3205(80)90358-6","volume":"26","author":"JH Thurston","year":"1980","unstructured":"Thurston JH, Hauhart RE, Dirgo JA (1980) Taurine: a role in osmotic regulation of mammalian brain and possible clinical significance. Life Sci 26:1561\u20131568","journal-title":"Life Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Taurine 10"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-024-1079-2_56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T13:18:05Z","timestamp":1709644685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-024-1079-2_56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9789402410778","9789402410792"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-94-024-1079-2_56","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2017]]}}}